

Phone: +44 (0)1462 439877



Email: info@qvigilance.com

Submit an RFI

QVigilance
  • About Us
    • Meet the Team
  • Global Services
    • Safety Database
    • Case Processing and Reporting
    • Global & Local Literature screening
    • Aggregate Report
    • Signal Management
    • Risk Management
    • Regulatory Intelligence
    • Medical Device Vigilance
    • Pharmacovigilance Consultancy
  • EU Services
    • EU and UK QPPVs
    • EudraVigilance Services
    • PSMF Management
  • Blog & Regulatory Updates
    • QVigilance News
  • Resources
    • What is Medical Information
  • Events
  • Contact Us

Regulatory Intelligence

Health Canada: Discontinuation of Acknowledgement Letters for Regulatory Activities

Health Canada: Discontinuation of Acknowledgement Letters for Regulatory Activities

Mar 5, 2019 | Regulatory Intelligence

On 30th Jan 2019, Health Canada issued a notice that effective from 01st April 2019, it will discontinue issuing…

‘No deal’ Brexit regulatory advice on medicines, devices and clinical trials

‘No deal’ Brexit regulatory advice on medicines, devices and clinical trials

Oct 26, 2018 | Regulatory Intelligence

In this ‘Brexit News’ close-up our Regulatory Intelligence team will provide a commentary and updates on recent…

Recent Posts

  • Pharmacovigilance Outsourcing: Benefits of Working with a Specialist Provider
  • New PV practice guidance on Pregnancy Prevention Programmes by EMA
  • UK Government publishes updated pharmacovigilance guidance for UK medicines
  • Updated guidance on QPPV and PSMF requirements from 01 Jan 2021
  • What you need to know about the GVP Paediatric Guideline

Categories

  • Brexit News
  • Brexit Updates
  • EU Regulation
  • GVP
  • Pharmacovigilance Blog
  • PSMF
  • Regulatory Intelligence

Archives

  • November 2025
  • April 2022
  • September 2020
  • September 2019
  • July 2019
  • March 2019
  • February 2019
  • October 2018
  • September 2018
Follow us
  • Follow
  • Follow

Submit an RFI

Address: 9-11 Bancroft Court, Bevan House, Hitchin, Hertfordshire, SG5 1LH, UK

Email: info@qvigilance.com

Phone: +44 01462 439877

Latest Posts

Health Canada: Discontinuation of Acknowledgement Letters for Regulatory Activities

5 Mar, 2019

‘No deal’ Brexit regulatory advice on medicines, devices and clinical trials

26 Oct, 2018

Fast Links

Home
About Us
Global Services
EU Services
Blog & Regulatory Updates
Resources
Events
Contact Us

© 2025 Qvigilance

  • Follow
  • Follow